Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Pancreatic Neoplasms × relacorilant × Clear all

Phase

Status

Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1

Interventions

Gemcitabine 99 130-nm albumin-bound paclitaxel 34 Oxaliplatin 28 Capecitabine 27 Fluorouracil 25 Albumin-Bound Paclitaxel 23 Leucovorin 19 Irinotecan 18 Erlotinib Hydrochloride 14 Radiosurgery 11 Cyclophosphamide 11 pembrolizumab 10 Radiotherapy 10 Nivolumab 10 Bevacizumab 10 Surgical Procedures, Operative 9 avelumab 7 Docetaxel 7 Taxes 6 Cisplatin 6 ruxolitinib 5 folfirinox 5 Paclitaxel 5 Everolimus 5 Cetuximab 5 ALT-803 5 spartalizumab 4 Specimen Handling 4 S 1 (combination) 4 Radiotherapy, Intensity-Modulated 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04329949 2023-11-18

RELIANT

Corcept Therapeutics

Phase 3 Terminated

43 enrolled 17 charts

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡